S&P 500   3,692.39 (+0.70%)
DOW   30,165.19 (+0.65%)
QQQ   305.05 (+0.25%)
AAPL   122.00 (-0.76%)
MSFT   213.41 (-0.39%)
FB   280.04 (-0.64%)
GOOGL   1,821.44 (-0.02%)
AMZN   3,162.18 (-0.77%)
TSLA   593.81 (+0.07%)
NVDA   539.30 (+0.65%)
BABA   266.92 (+0.00%)
CGC   28.61 (-0.07%)
GE   10.88 (+2.64%)
MU   73.23 (+4.76%)
AMD   93.94 (+1.77%)
T   29.47 (+0.82%)
NIO   42.75 (-5.73%)
F   9.32 (+1.19%)
ACB   10.81 (-3.83%)
BA   232.47 (-1.99%)
NFLX   498.40 (+0.18%)
GILD   61.43 (+0.94%)
DIS   153.65 (+0.27%)
S&P 500   3,692.39 (+0.70%)
DOW   30,165.19 (+0.65%)
QQQ   305.05 (+0.25%)
AAPL   122.00 (-0.76%)
MSFT   213.41 (-0.39%)
FB   280.04 (-0.64%)
GOOGL   1,821.44 (-0.02%)
AMZN   3,162.18 (-0.77%)
TSLA   593.81 (+0.07%)
NVDA   539.30 (+0.65%)
BABA   266.92 (+0.00%)
CGC   28.61 (-0.07%)
GE   10.88 (+2.64%)
MU   73.23 (+4.76%)
AMD   93.94 (+1.77%)
T   29.47 (+0.82%)
NIO   42.75 (-5.73%)
F   9.32 (+1.19%)
ACB   10.81 (-3.83%)
BA   232.47 (-1.99%)
NFLX   498.40 (+0.18%)
GILD   61.43 (+0.94%)
DIS   153.65 (+0.27%)
S&P 500   3,692.39 (+0.70%)
DOW   30,165.19 (+0.65%)
QQQ   305.05 (+0.25%)
AAPL   122.00 (-0.76%)
MSFT   213.41 (-0.39%)
FB   280.04 (-0.64%)
GOOGL   1,821.44 (-0.02%)
AMZN   3,162.18 (-0.77%)
TSLA   593.81 (+0.07%)
NVDA   539.30 (+0.65%)
BABA   266.92 (+0.00%)
CGC   28.61 (-0.07%)
GE   10.88 (+2.64%)
MU   73.23 (+4.76%)
AMD   93.94 (+1.77%)
T   29.47 (+0.82%)
NIO   42.75 (-5.73%)
F   9.32 (+1.19%)
ACB   10.81 (-3.83%)
BA   232.47 (-1.99%)
NFLX   498.40 (+0.18%)
GILD   61.43 (+0.94%)
DIS   153.65 (+0.27%)
S&P 500   3,692.39 (+0.70%)
DOW   30,165.19 (+0.65%)
QQQ   305.05 (+0.25%)
AAPL   122.00 (-0.76%)
MSFT   213.41 (-0.39%)
FB   280.04 (-0.64%)
GOOGL   1,821.44 (-0.02%)
AMZN   3,162.18 (-0.77%)
TSLA   593.81 (+0.07%)
NVDA   539.30 (+0.65%)
BABA   266.92 (+0.00%)
CGC   28.61 (-0.07%)
GE   10.88 (+2.64%)
MU   73.23 (+4.76%)
AMD   93.94 (+1.77%)
T   29.47 (+0.82%)
NIO   42.75 (-5.73%)
F   9.32 (+1.19%)
ACB   10.81 (-3.83%)
BA   232.47 (-1.99%)
NFLX   498.40 (+0.18%)
GILD   61.43 (+0.94%)
DIS   153.65 (+0.27%)
Log in
NASDAQ:EYEN

Eyenovia Stock Forecast, Price & News

$3.87
+0.26 (+7.20 %)
(As of 12/4/2020 03:18 PM ET)
Add
Compare
Today's Range
$3.67
Now: $3.87
$3.88
50-Day Range
$3.27
MA: $3.46
$3.75
52-Week Range
$1.11
Now: $3.87
$6.92
Volume3,944 shs
Average Volume398,465 shs
Market Capitalization$96.30 million
P/E RatioN/A
Dividend YieldN/A
Beta2.24
Eyenovia, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. The company offers a piezo-print technology to deliver micro-doses of micro-therapeutics for the eyes. Its products include MicroProst, MicroStat, MicroTears, and MicroPine. The firm is currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression and mydriasis. The company was founded by Sean Ianchulev on March 12, 2014 and is headquartered in New York, NY.
Eyenovia logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.4Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.59 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:EYEN
CUSIPN/A
Phone(917) 289-1117
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$0.75 per share

Profitability

Net Income$-21,160,000.00

Miscellaneous

Market Cap$96.30 million
Next Earnings Date3/24/2021 (Estimated)
OptionableNot Optionable
$3.87
+0.26 (+7.20 %)
(As of 12/4/2020 03:18 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive EYEN News and Ratings via Email

Sign-up to receive the latest news and ratings for EYEN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Eyenovia (NASDAQ:EYEN) Frequently Asked Questions

How has Eyenovia's stock been impacted by COVID-19 (Coronavirus)?

Eyenovia's stock was trading at $2.90 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, EYEN shares have increased by 32.1% and is now trading at $3.83.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Eyenovia?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Eyenovia in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Eyenovia
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Eyenovia?

Wall Street analysts have given Eyenovia a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Eyenovia wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Eyenovia's next earnings date?

Eyenovia is scheduled to release its next quarterly earnings announcement on Wednesday, March 24th 2021.
View our earnings forecast for Eyenovia
.

How were Eyenovia's earnings last quarter?

Eyenovia, Inc. (NASDAQ:EYEN) announced its quarterly earnings data on Tuesday, November, 10th. The company reported ($0.23) earnings per share for the quarter, missing the consensus estimate of ($0.18) by $0.05.
View Eyenovia's earnings history
.

What price target have analysts set for EYEN?

4 Wall Street analysts have issued 12 month target prices for Eyenovia's shares. Their forecasts range from $6.00 to $19.00. On average, they anticipate Eyenovia's stock price to reach $12.00 in the next twelve months. This suggests a possible upside of 213.3% from the stock's current price.
View analysts' price targets for Eyenovia
.

Are investors shorting Eyenovia?

Eyenovia saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 62,600 shares, an increase of 24.2% from the October 31st total of 50,400 shares. Based on an average daily trading volume, of 179,600 shares, the days-to-cover ratio is currently 0.3 days. Currently, 0.4% of the shares of the stock are sold short.
View Eyenovia's Short Interest
.

Who are some of Eyenovia's key competitors?

What other stocks do shareholders of Eyenovia own?

Who are Eyenovia's key executives?

Eyenovia's management team includes the following people:
  • Sean Ianchulev, President, CEO, Director & Chief Medical Officer
  • John P. Gandolfo, Chief Financial Officer & Secretary
  • Luke Clauson, VP-Engineering, Research & Development
  • Jennifer Clasby, Vice President-Clinical Operations
  • Michael M. Rowe, Vice President-Commercial

When did Eyenovia IPO?

(EYEN) raised $30 million in an initial public offering (IPO) on Thursday, January 25th 2018. The company issued 2,700,000 shares at a price of $10.00-$12.00 per share. Ladenburg Thalmann and Roth Capital Partners​ acted as the underwriters for the IPO.

What is Eyenovia's stock symbol?

Eyenovia trades on the NASDAQ under the ticker symbol "EYEN."

Who are Eyenovia's major shareholders?

Eyenovia's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (0.24%), Shone Asset Management LLC (0.09%) and National Asset Management Inc. (0.06%). Company insiders that own Eyenovia stock include Curt H Labelle, John P Gandolfo, Stuart M Grant and Tsontcho Ianchulev.
View institutional ownership trends for Eyenovia
.

Which institutional investors are buying Eyenovia stock?

EYEN stock was acquired by a variety of institutional investors in the last quarter, including Shone Asset Management LLC, National Asset Management Inc., and BlackRock Inc.. Company insiders that have bought Eyenovia stock in the last two years include Curt H Labelle, John P Gandolfo, Stuart M Grant, and Tsontcho Ianchulev.
View insider buying and selling activity for Eyenovia
.

How do I buy shares of Eyenovia?

Shares of EYEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Eyenovia's stock price today?

One share of EYEN stock can currently be purchased for approximately $3.83.

How big of a company is Eyenovia?

Eyenovia has a market capitalization of $95.31 million. The company earns $-21,160,000.00 in net income (profit) each year or ($1.47) on an earnings per share basis.

What is Eyenovia's official website?

The official website for Eyenovia is www.eyenoviabio.com.

How can I contact Eyenovia?

Eyenovia's mailing address is 295 MADISON AVENUE SUITE 2400, NEW YORK NY, 10017. The company can be reached via phone at (917) 289-1117 or via email at [email protected]

This page was last updated on 12/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.